On June 20, Gelonhui reported that Haohai Biotech (06826.HK) has adjusted the upper limit of the repurchase price of A shares in accordance with relevant regulations of the repurchase plan. The adjustment was made because the final dividend distribution and A-share capitalization issuance of the company's A shares were completed as of June 20, 2024 (i.e., the ex-dividend date of A shares). After adjustment, the repurchase price of A shares will not exceed RMB 92.48 per share (including) instead of no more than RMB 130.00 per A share (including).
昊海生物科技(06826.HK)：回购A股价格上限调整为不超过人民币92.48元╱股(含)
Haohai Biotec (06826.HK): The upper limit of the repurchase price for A shares has been adjusted to no more than RMB 92.48 per share (including).
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.